MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$6,479K
Net loss
-$77,905K
Total other income,
net
$6,209K
Other expense, net
-$270K
Loss from operations
-$84,114K
Total operating
expenses
$84,114K
Research and development
$59,990K
General and
administrative
$24,124K
Back
Back
Income Statement
source: myfinsight.com
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)